Liposomes, marvels in biopharmaceutics, are microscopic vesicles composed of lipid bilayers. These versatile structures hold immense promise in drug delivery, encapsulating pharmaceutical agents within their lipid layers. The liposome's unique ability to mimic cell membranes enables targeted drug delivery, enhancing therapeutic efficacy while minimizing side effects.
In the realm of biopharmaceutics, liposomes serve as ingenious carriers for both hydrophobic and hydrophilic drugs, offering a controlled and sustained release. Their biocompatibility and customizable surface properties facilitate interaction with specific cell types, allowing for precision in therapeutic interventions. This has profound implications for treating various diseases, including cancer, infections, and inflammatory disorders.
The flexibility of liposomes extends to their adaptability for incorporating imaging agents, making them invaluable tools in diagnostics. As biopharmaceutics continues to evolve, liposomes stand at the forefront, ushering in a new era of targeted and personalized medicine, poised to revolutionize the landscape of drug delivery and therapeutic interventions.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil